Jewell Christopher M 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Jewell Christopher M
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-01-03$16.72/sh−1,264$21,136→ 54,776 total - Sale
Common Stock
2025-01-06$16.83/sh−1,286$21,646→ 53,490 total
Footnotes (1)
- [F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.